A detailed history of Headlands Technologies LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Headlands Technologies LLC holds 3,971 shares of ZLAB stock, worth $67,705. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,971
Holding current value
$67,705
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$15.95 - $26.8 $63,337 - $106,422
3,971 New
3,971 $63,000
Q3 2023

Nov 09, 2023

SELL
$22.72 - $31.49 $78,906 - $109,364
-3,473 Reduced 99.06%
33 $0
Q2 2023

Aug 03, 2023

BUY
$25.3 - $39.67 $88,701 - $139,083
3,506 New
3,506 $97,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.67B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.